TCM Intrinsic Value
TCM (TCMLMTD) median intrinsic value is ₹28.75 from 2 valuation models (range ₹20–₹29), vs current price ₹56.42 — -49.0% downside (Trading Above Calculated Value), margin of safety -96.2%. For current market price and key ratios, visit TCMLMTD stock price BSE.
TCMLMTD Valuation Methods Summary — DCF, Graham Number & P/E
TCM intrinsic value across 2 models vs current price ₹56.42 — upside/downside and value range per method. Check TCM networth to track the company's total market size over time.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹28.75 | ₹25.88 - ₹31.63 | -49.0% | Book Value/Share: ₹28.75, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹20.00 | ₹18.00 - ₹22.00 | -64.6% | Revenue/Share: ₹25.00, P/S: 0.8x |
TCMLMTD Intrinsic Value vs Market Price — All Valuation Models
TCM fair value range ₹20–₹29 vs current market price ₹56.42 across 2 valuation models. See TCMLMTD P/B ratio history to compare market price against book value per share.
TCMLMTD Intrinsic Value Analysis — Undervalued or Overvalued?
TCM median intrinsic value ₹28.75, current price ₹56.42 — Trading Above Calculated Value by 49.0%, margin of safety -96.2%.
What is the intrinsic value of TCMLMTD?
Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of TCM (TCMLMTD) is ₹28.75 (median value). With the current market price of ₹56.42, this represents a -49.0% variance from our estimated fair value.
The valuation range spans from ₹20.00 to ₹28.75, indicating ₹20.00 - ₹28.75.
Is TCMLMTD undervalued or overvalued?
Based on our multi-method analysis, TCM (TCMLMTD) appears to be trading above calculated value by approximately 49.0%.
TCMLMTD Financial Health — Key Ratios vs Industry Benchmarks
TCM financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 4.89 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -34.8% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -24.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.24x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
TCMLMTD Cash Flow Quality — Operating & Free Cash Flow
TCM operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹-5 Cr | ₹-7 Cr | Negative Cash Flow | 3/10 |
| March 2025 | ₹-10 Cr | ₹-10 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-11 Cr | ₹-11 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-4 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |